Diabetes tech: a catalyst rich sector with a dazzling future
Aldeyra's roller coaster month ends with 'positive' phase 2 chronic cough readout
Lundbeck replaces retiring CEO Deborah Dunsire with UCB exec after breaking sales record
Sanofi's $1.1B eczema drug hits midphase goal, spurring talk of phase 3 and new indications
*please scroll down for all the latest news*
